Boosted by the vaccine: lessons from COVID-19 for the future of the life sciences
The COVID-19 pandemic showcased the great strengths of the UK’s life sciences ecosystem. With regulators, academics, private firms, and the NHS pulling together, the UK was able to develop an effective vaccine much more quickly than many – including Chief Medical Officer Sir Chris Whitty – had ever thought possible.
This paper explores the factors that drove this success and identifies what lessons should be taken forward - from the need for sustained regulatory flexibility, to the essential role of data sharing and access to growth capital - to ensure the UK retains its place at the forefront of an ever more competitive global life sciences industry.
The report presents five policy recommendations:
- NHS England should complete a rapid review of best practice in the four existing NHS innovation hubs, to inform a two-year trial of hubs in each Integrated Care System across England
- The Government should create an annual re-pricing mechanism for services provided by the Medicines and Healthcare products Regulatory Agency (MHRA), to place the regulator on a stable, long-term financial footing
- NHS Digital should develop a new data-sharing pathway within the NHS App, including processes for users to opt-in to sharing or trial participation and for researchers to contact eligible patients
- The Government should introduce a package of measures to significantly enhance the UK’s growth capital offering in the life sciences, centred around a variant of the successful French Tibi scheme
- The Government should support the development of new technologically-specialised growth clusters, by focusing Investment Zones on academic institutions with a track record of exemplary research in the life sciences
Our work on Boosted by the vaccine was kindly supported by Moderna.
|Tweets by @reformthinktank
Latest News from
The State of the State 202424/01/2024 13:05:00
The ‘State of the State’, in partnership with Deloitte, explores key issues. facing the UK government and public services.
Devolve by default: decentralisation and a redefined Whitehall04/01/2024 15:05:00
At present, a great deal of Whitehall’s time and resources are absorbed by unnecessary centralisation: micromanagement of purely local affairs, management of bid-in pots for local actors, and the development of policy which would be better handled differently from place to place.
Addressing the silent pandemic: the UK’s response to AMR06/11/2023 14:25:00
This event write-up brings together ideas generated at a Reform policy roundtable, led by Russell Hope, Deputy Director of the AMR Division at the UKHSA.
Civil unrest: a portrait of the Civil Service through Brexit, the pandemic and political turbulence31/10/2023 12:05:00
Civil unrest is based on interviews with 50 current and former civil servants, mostly below SCS. Rare in Whitehall analysis, it provides a first-hand account of their experience over the past few years of relative turbulence.
The hidden waitlist27/10/2023 12:05:00
Follow up appointments are crucial to the health and safety of patients, and can include monitoring for the recurrence of cancer, assessing whether someone’s medication is correct, and managing chronic conditions to reduce the risk of deterioration.
A neighbourhood strategy for national renewal26/10/2023 15:05:00
We are at a crucial moment for England’s ‘left behind’ neighbourhoods, and decisions made in the next few years will define their prospects for decades to come.
Health security from the ground up: 5 lessons for the future of the UKHSA03/08/2023 13:05:00
There were many strengths to the nation’s COVID-19 response, from the development of the vaccine to the resilience of healthcare workers on the frontline.
Breaking down the barriers: why Whitehall is so hard to reform01/08/2023 11:25:00
There is remarkable consensus – including among many working within the civil service – on the key flaws in the Whitehall machine.